Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 5/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 3/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | ATR | Q13535 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL34876 | 0.95 | BBOX1 (0.41) | BBOX1ACHEENPP2APPFAAH | |
| SCHEMBL918430 | 0.82 | BBOX1 (0.58) | BBOX1ACHEENPP2APPMEN1 | |
| SCHEMBL34763 | 0.79 | BBOX1 (0.61) | BBOX1ACHEENPP2APPMEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL34541 | 0.79 | BBOX1 (0.47) | BBOX1ACHEENPP2APPMEN1 | |
| SCHEMBL34764 | 0.78 | BBOX1 (0.54) | BBOX1ACHEENPP2APPMEN1 | |
| Trifluoroacetic Acid SCHEMBL34258 | 0.78 | FAAH (0.35) | BBOX1APPFAAHCES2CES1 | |
| Trifluoromethanesulfonic Acid SCHEMBL34542 | 0.78 | BBOX1 (0.41) | BBOX1ACHEENPP2APPMEN1 | |
| Trifluoroacetic Acid SCHEMBL1981477 | 0.77 | DNM1 (0.44) | BBOX1ACHEFAAHCES2CES1 | |
| Trifluoroacetic Acid SCHEMBL34745 | 0.77 | FAAH (0.44) | FAAHCES2CES1 | |
| SCHEMBL34691 | 0.76 | BBOX1 (0.50) | BBOX1ACHEENPP2APPMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473277-B1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION OR ACID-FUNCTIONALIZED IONIC LIQUID | UNIV DENMARK TECH DTU (DK) | 2019-07-03 | — | — | EP | disclosed |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | UNIV DENMARK TECH DTU (DK) | 2017-11-30 | — | — | US | disclosed |
| CN-102625731-B | Comprise the palladium catalyst system of the ionic liquid of zwitter-ion and/or acid functionalization | DANMARKS TEKNISKE UNIVERSITET (DK) | 2016-04-06 | — | — | CN | disclosed |
| CN-102625731-A | Palladium catalyst system comprising zwitterion and/or acid-functionalized ionic liquid | TECHNICAL UNIVERISTY OF DENMARK | 2012-08-01 | — | — | CN | disclosed |
| EP-2473277-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALIZED IONIC LIQUID | Technical University of Denmark (DK) | 2012-07-11 | — | — | EP | disclosed |
| US-20110065950-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2011-03-17 | — | — | US | disclosed |
| WO-2011026860-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALIZED IONIC LIQUID | TECHNICAL UNIVERISTY OF DENMARK (DK) | 2011-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065950-A1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID | PDCD2L, PCCA, PDK2 | BBOX1 1023/4885ACHE 2932/4885ENPP2 2417/4885 |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | PDCD2L, PCCA, PDK2 | BBOX1 1023/4885ACHE 2932/4885ENPP2 2417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.